PubMed Health⌕ Search

Biomedical subjects

M S Ruttley

Publications and source records attributed to M S Ruttley.

At least 19 recordsLinked to original sources
PubMed2000

Traumatic priapism: an unusual cycling injury.

A case is reported of a 35 year old man who sustained an injury to the perineum in a cycling accident which resulted in a traumatic priapism. After confirmation of the diagnosis by Doppler sonography and angiography, therapeutic selective arterial embolisation was followed by successful detumescence of the penis and subsequent return of normal erectile function. It is suggested that percutaneous embolisation of the lacerated cavernosal artery is a safe and effective minimally invasive treatment for this uncommon condition.

Adult↗
PubMed1997

Aortotracheal fistula: demonstration by computerized tomography.

Aortotracheal fistula is a rare condition that is invariably fatal if not diagnosed and surgically treated. Patients usually present with small intermittent haemoptysis. In cases of aortotracheal fistula bronchoscopy may be both misleading and dangerous. The findings using computerized tomography (CT) are usually non-diagnostic. We present a case of aortotracheal fistula in which CT established the diagnosis by demonstrating the fistula as a continuous tract between the aorta and the trachea. CT should be considered in the initial investigation of patients suspected to have such a disease.

Aged↗
PubMed1997

The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty.

OBJECTIVE: To investigate the effects of two platelet inhibitors, aspirin and iloprost, on platelet uptake and restenosis at the site of angioplasty in patients undergoing femoral or popliteal angioplasty. EXPERIMENTAL DESIGN: Prospective, open, randomised group comparison. SETTING: Two university hospitals. PATIENTS: 43 patients undergoing femoral or popliteal angioplasty were randomised. INTERVENTIONS: Patients received either aspirin (300 mg/day), iloprost (8 hours/day i.v. infusion) or no antiplatelet medication during angioplasty and on the subsequent two days. MEASURES: Platelet uptake was measured using 111Indium-labelled platelets. Restenosis was assessed by repeat angiography at 3 months and clinical symptoms up to 12 months. RESULTS: Median changes in platelet uptake were similar in the three treatment groups, but all platelet radioactivity ratios > 2.0 occurred in the control group. Restenosis at 3 months was observed in 3 control, 5 aspirin and 1 iloprost patient. Further surgical intervention was performed in 3 control and 3 aspirin patients, but in none of the iloprost patients up to 12 months after angioplasty. CONCLUSIONS: Antiplatelet therapy may prevent large increases in platelet deposition at the angioplasty site, but the link between platelet deposition and restenosis was not substantiated in this study.

Aged↗
PubMed1996

Follow-up of chronic thoracic aortic dissection: comparison of transesophageal echocardiography and magnetic resonance imaging.

Because survivors of thoracic aortic dissection require follow-up to detect prognostic factors such as intimal tears, persistent flow in the false lumen, and complications associated with grafts, we compared transesophageal echocardiography (TEE) with magnetic resonance imaging (MRI) prospectively in 14 patients 1 year after their initial examination. Residual dissection was identified by both techniques in 11 patients. Flow and/or thrombus in the false lumen were detected by TEE in 10 (91 %) and 6 (55%) patients, respectively, and by MRI in 9 (82%) and 5 (45%), respectively (p = NS); more tears were detected by TEE (2.5 +/- 1.4 per patient vs 0.2 +/- 0.4; p < 0.005). Satisfactory delineation of a graft in the ascending aorta was noted in all 8 (100%) of the surgically treated patients by TEE compared with 4 (50%) by MRI (p < 0.005). The upper ascending aorta was visualized clearly in fewer patients by TEE than by MRI (7 [50%] vs 13 [93%]; p < 0.05), as were the origins of the head and neck vessels (10 [71%] vs 13 [93%], p = NS). We conclude that TEE and MRI are both suitable techniques for the follow-up of patients with aortic dissection. TEE is more sensitive in identifying prognostic factors. MRI has a complementary role, particularly in visualization of the upper ascending aorta and the head and neck vessels.

Adult↗
PubMed1994

Corticosteroid prophylaxis for patients with increased risk of adverse reactions to intravascular contrast agents: a survey of current practice in the UK.

There is no definite experimental evidence that prophylactic corticosteroids reduce the frequency or severity of adverse effects from low-osmolar contrast agents in patients at increased risk of reaction. There is no consensus in terms of how prophylaxis should be conducted. We have studied current radiologists' practice in the UK by sending postal questionnaires to 212 radiologists randomly selected from a list of current consultants who are Fellows of the Royal College of Radiologists. One hundred and seventy (80.2%) of the 212 questionnaires were completed. The majority of radiologists routinely use non-ionic low osmolar contrast media for intravenous administration, only 30 (17.6%) routinely using conventional ionic agents and six (3.5%) ionic low osmolar agents. All 170 use low osmolar contrast media for those patients perceived to be at increased risk of adverse reactions. Seventy-six radiologists (44.7%) never use steroid cover. There is no consistent practice amongst the 94 consultants (55.3%) who do use steroid cover. The indications for prophylaxis vary, as do the corticosteroid used and the dose regime employed. The total dose used varied from the equivalent of 7.5 mg to 400 mg of prednisolone, and the duration of prophylaxis varied from a single dose to a 4 day course. One hundred and forty-two radiologists (83.5%) would welcome nationally agreed guidelines for the use of steroid cover. The great variation in the use of steroid cover in the UK reflects the lack of clear evidence of its benefit in combination with low osmolar contrast media.

Adrenal Cortex Hormones↗
PubMed1994

Case report: traumatic aortic rupture: demonstration by magnetic resonance imaging.

Traumatic rupture of the aorta is a major cause of morbidity and mortality in rapid deceleration road traffic accidents, with an immediate mortality of 85%. Of the 15% that survive the initial injury, approximately 50% will die within 24 h if left untreated. Prompt diagnosis and early surgical treatment are necessary if such patients are to survive. Aortography is the standard investigation of choice and provides a rapid, sensitive test of aortic rupture. Other modalities, such as plain chest radiography, computed tomography (CT) and ultrasound may also play a role in diagnosis. Magnetic resonance imaging (MRI), with its multi-planar imaging capability, is now widely used for imaging non-traumatic disorders of the aorta. However, its use in traumatic rupture has been limited by difficulties in monitoring and in access to the patient during the scan. We present a patient who survived the initial injury, when the diagnosis of aortic rupture was not suspected. and presented 3 weeks later with chest pain. An MRI scan was feasible as the patient was haemodynamically stable, and it provided an elegant non-invasive means of diagnosis, so that aortography was not necessary in this case. Although aortography is likely to remain the investigation of choice in the acute situation, MRI is a useful alternative in selected cases.

Accidents, Traffic↗
PubMed1993

Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide.

Iodixanol is a new non-ionic, dimeric contrast medium (CM) which is formulated to be isotonic with blood in all clinically relevant concentrations. This is a report of a parallel, double-blind study comparing the safety and efficacy of iodixanol with iopromide (Ultravist) in aortofemoral arteriography. One hundred consecutive, eligible patients scheduled to undergo peripheral arteriography were entered into the study and randomly allocated to receive one or other CM. Radiographic quality, discomfort, adverse events, femoral blood flow and renal function were examined. Ninety-five patients were successfully included in the study. Radiographic quality (efficacy) was found to be similar in both groups. Three patients (6%) in the iodixanol group and five patients (11%) in the iopromide group reported adverse events. In this respect there was no statistically significant difference between the two groups (P = 0.48), and all adverse events were mild and transient. Forty-six (97%) patients in the iodixanol group and 45 (100%) patients in the iopromide group experienced a sensation of warmth (discomfort) in connection with one or more of the injections. There was no statistically significant difference in the frequency of discomfort in the two groups. However, the intensity of warmth was significantly milder following iodixanol than after iopromide (P = 0.003, two-sided Mantel-Haenszel test). The mean percentage increase in femoral blood flow was found to be less with iodixanol (43.4%) than with iopromide (96.3%) (P < 0.05, Student's t-test). Renal function was affected slightly after administration of both CM. Serum creatinine and creatinine clearance were affected more by iodixanol than by iopromide, while the excretion of tubular enzymes was more affected by iopromide. In conclusion, this comparison between iodixanol and iopromide showed both contrast media to be safe, effective and well tolerated and the only major difference between them was in their effect on femoral blood flow.

Aged↗
PubMed1991

Percutaneous transluminal angioplasty of the subclavian artery.

A series of 12 consecutive cases of symptomatic subclavian artery stenosis or occlusion treated by percutaneous transluminal angioplasty are described. In seven cases stenoses were successfully dilated, and in four out of five cases occlusions were recanalised using standard angioplasty technique. Complications were trivial and did not prolong hospital stay, all patients being discharged within 48 h of the procedure. Percutaneous transluminal angioplasty of the subclavian artery is a safe, effective procedure and recommended as the treatment of first choice in symptomatic subclavian stenosis or occlusion.

Adult↗